Tonix Pharmaceuticals Ownership | Who Owns Tonix Pharmaceuticals?


OverviewForecastRevenueFinancialsChart

Tonix Pharmaceuticals Ownership Summary


Tonix Pharmaceuticals is owned by 13.29% institutional investors, 0.13% insiders, and 86.58% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.38% of TNXP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Tonix Pharmaceuticals shares.

TNXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTonix Pharmaceuticals13.29%0.13%86.58%
SectorHealthcare Stocks 35.34%11.88%52.77%
IndustryBiotech Stocks 35.37%11.83%52.80%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de968.18K11.38%$13.31M
Vanguard group673.61K7.55%$10.52M
Citadel advisors468.71K5.51%$6.44M
Geode capital management313.29K3.68%$4.31M
Balyasny asset management313.08K3.68%$4.30M
Ubs group231.68K2.72%$3.19M
State street230.61K2.71%$3.17M
Millennium management219.67K2.58%$3.02M
Aqr capital management161.21K1.89%$2.22M
Point72 asset management125.41K1.47%$1.72M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp63.54K0.62%$873.67K
Xtx topco20.30K0.03%$490.35K
Sjs investment consulting10.00K0.02%$137.56K
Susquehanna portfolio strategies41.45K0.02%$1.00M
Balyasny asset management313.08K0.01%$4.30M
Capital fund management62.95K0.00%$1.52M
Quadrature capital17.41K0.00%$239.39K
Gen-wealth partners533.000.00%$7.33K
Point72 asset management125.41K0.00%$1.72M
State of wyoming1.18K0.00%$16.17K

Top Buyers

HolderShares% AssetsChange
Citadel advisors468.71K0.00%468.71K
Millennium management219.67K0.00%196.73K
Aqr capital management161.21K0.00%141.19K
Ubs group231.68K0.00%140.22K
Balyasny asset management313.08K0.01%127.73K

Top Sellers

HolderShares% AssetsChange
Point72 asset management125.41K0.00%-494.62K
Davidson kempner capital management lp---90.01K
Northern trust100.13K0.00%-74.75K
Squarepoint ops---31.63K
Jane street group---30.63K

New Positions

HolderShares% AssetsChangeValue
Citadel advisors468.71K0.00%468.71K$6.44M
Vanguard fiduciary trust84.27K0.00%84.27K$1.16M
Superstring capital management lp63.54K0.62%63.54K$873.67K
Capital fund management62.95K0.00%62.95K$1.52M
Wellington management group llp26.46K0.00%26.46K$639.39K

Sold Out

HolderChange
Raymond james financial-7.00
Pinnacle wealth planning services-342.00
Amalgamated bank-365.00
Fny investment advisers-1.10K
Jt stratford-6.44K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202635-53.33%1,130,973-69.78%130.76%21-60.38%5-37.50%
Dec 31, 202548-22.58%2,487,1385.52%272.69%33-25.00%5-28.57%
Sep 30, 20256042.86%2,353,52474.63%329.49%4330.30%716.67%
Jun 30, 20254684.00%1,387,046186.68%1828.41%37164.29%6-45.45%
Mar 31, 20251-96.97%10,000-99.93%-0.40%1-96.15%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv359.73K2.53%-
iShares Russell 2000 ETF316.89K2.23%2.68K
Vanguard Institutional Extnd Mkt Idx Tr146.96K1.03%18.44K
Nuveen Quant Small Cap Equity R681.40K0.93%81.40K
iShares Russell 2000 Value ETF114.97K0.81%623.00
Fidelity Small Cap Index113.58K0.80%964.00
NT Quality Small Cap Value80.05K0.63%-5.20K
Northern Small Cap Value80.05K0.63%-5.20K
Russell 2000 Equity Index Fund B72.72K0.51%23.48K
Fidelity Extended Market Index70.45K0.50%8.36K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 31, 2026LEDERMAN SETH Chief Executive OfficerBuy$63.10K
Mar 18, 2026LEDERMAN SETH Chief Executive OfficerBuy$223.35K
Aug 21, 2025Taylor Carolyn E.-Buy$15.06K
Aug 20, 2025Treco James-Buy$9.00K
May 15, 2025LEDERMAN SETH Chief Executive OfficerBuy$86.20K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q12-
2025 Q4--
2025 Q32-
2025 Q21-

TNXP Ownership FAQ


Who Owns Tonix Pharmaceuticals?

Tonix Pharmaceuticals shareholders are primarily institutional investors at 13.29%, followed by 0.13% insiders and 86.58% retail investors. The average institutional ownership in Tonix Pharmaceuticals's industry, Biotech Stocks , is 35.37%, which Tonix Pharmaceuticals falls below.

Who owns the most shares of Tonix Pharmaceuticals?

Tonix Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (968.18K shares, 11.38%), Vanguard group (673.6K shares, 7.55%), and Citadel advisors (468.71K shares, 5.51%). Together, they hold 24.43% of Tonix Pharmaceuticals’s total shares outstanding.

Does Blackrock own Tonix Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Tonix Pharmaceuticals.

Who is Tonix Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Tonix Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.62% of its assets in 63.54K Tonix Pharmaceuticals shares, valued at 873.68K$.

Who is the top mutual fund holder of Tonix Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tonix Pharmaceuticals shares, with 2.53% of its total shares outstanding invested in 359.73K Tonix Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools